Diffuse follicle center lymphoma, extranodal and solid organ sites
ICD-10 C82.59 is a billable code used to indicate a diagnosis of diffuse follicle center lymphoma, extranodal and solid organ sites.
Diffuse follicle center lymphoma (DFCL) is a subtype of non-Hodgkin lymphoma characterized by the proliferation of neoplastic B-cells that originate from the germinal centers of lymphoid follicles. This specific code, C82.59, refers to cases where the lymphoma manifests in extranodal sites or solid organs, which can include the gastrointestinal tract, skin, or other organs outside of the lymphatic system. Clinically, patients may present with a variety of symptoms, including lymphadenopathy, splenomegaly, and B-symptoms such as fever, night sweats, and weight loss. The diagnosis is typically confirmed through histopathological examination and immunophenotyping. Staging of DFCL is crucial for determining the prognosis and treatment approach, which may include chemotherapy, immunotherapy, or radiation therapy, depending on the extent of the disease and patient-specific factors. The management of DFCL requires a multidisciplinary approach, often involving oncologists, hematologists, and radiologists.
Comprehensive pathology reports, staging information, and treatment plans.
Diagnosis and management of patients presenting with lymphadenopathy and B-symptoms.
Ensure accurate documentation of treatment response and any complications.
Detailed histological findings and immunophenotyping results.
Evaluation of biopsy specimens from suspected lymphoma cases.
Clear communication of findings to support accurate coding.
Used when a biopsy is performed to confirm the diagnosis of DFCL.
Pathology report detailing histological findings.
Pathologists should ensure clear communication of findings to support accurate coding.
Common symptoms include lymphadenopathy, splenomegaly, and B-symptoms such as fever, night sweats, and unexplained weight loss.
Diagnosis typically involves a combination of imaging studies, laboratory tests, and histopathological evaluation of biopsy specimens.
